CSPM EDP Sciences logo
Access to submission and peer review system
Search
Menu
All issues Volume 2 (2021) Vis Cancer Med, 2 (2021) 2 References
Open Access
Issue
Vis Cancer Med
Volume 2, 2021
Article Number 2
Number of page(s) 5
DOI https://doi.org/10.1051/vcm/2021001
Published online 22 April 2021
  1. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30(2):114–9. [CrossRef] [PubMed] [Google Scholar]
  2. Chen C, Yi W, Gao J, et al. Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients. Mol Clin Oncol. 2014;2(3):385–92. [CrossRef] [PubMed] [Google Scholar]
  3. Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2014;110(3):398–403. [Google Scholar]
  4. Zhang M-X, Li J, Shen G-P, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up (Oxford, England: 1990). Eur J Cancer. 2015;51(17):2587–95. [CrossRef] [PubMed] [Google Scholar]
  5. OuYang PY, Shi D, Sun R, et al. Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma. Oncotarget. 2016;7(22):33408–17. [CrossRef] [PubMed] [Google Scholar]
  6. Huang TL, Chien CY, Tsai WL, et al. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. Head Neck. 2016;38(Suppl 1):E1026–32. [CrossRef] [PubMed] [Google Scholar]
  7. Wei WI, Kwong DLW. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol. 2010;3(1):1–12. [CrossRef] [PubMed] [Google Scholar]
  8. Han F, Zhao C, Huang S-M, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol. 2012;24(8):569–76. [Google Scholar]
  9. Au KH, Ngan RKC, Ng AWY, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (–HKNPCSG 1301 study). Oral Oncol. 2018;77:16–21. [CrossRef] [PubMed] [Google Scholar]
  10. Chan JY, Wei WI. Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma. Expert Opin Ther Targets. 2012;16(Suppl 1):S111–7. [PubMed] [Google Scholar]
  11. Chan JY, Tsang RK, Wei WI. Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head Neck. 2015;37(4):487–92. [CrossRef] [PubMed] [Google Scholar]
  12. Chan JY, Wong ST, Chan RC, et al. Extracranial/intracranial vascular bypass and craniofacial resection: New hope for patients with locally advanced recurrent nasopharyngeal carcinoma. Head Neck. 2016;38(Suppl 1):E1404–12. [CrossRef] [PubMed] [Google Scholar]
  13. Chen MY, Xiang G, Wen WP, et al. Salvage surgical operation via endoscopic transnasal approach for local persistent or recurrent nasopharyngeal carcinoma. Chin J Cancer. 2007;26(7):673–8. [Google Scholar]
  14. Chen MY, Wen WP, Guo X, et al. Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. Laryngoscope. 2009;119(3):516–22. [CrossRef] [PubMed] [Google Scholar]
  15. Chen MY, Wang SL, Zhu YL, et al. Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head Neck. 2012;34(10):1383–8. [CrossRef] [PubMed] [Google Scholar]
  16. Liu J, Sun X, Liu Q, et al. Eustachian tube as a landmark to the internal carotid artery in endoscopic skull base surgery. Otolaryngology–Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2016;154(2):377–82. [Google Scholar]
  17. Liu CL, Hsu NI, Shen PH. Endoscopic endonasal nasopharyngectomy: tensor veli palatine muscle as a landmark for the parapharyngeal internal carotid artery. Int Forum Alergy Rhinol. 2017;7(6):624–8. [Google Scholar]
  18. Wang WH, Lieber S, Mathias RN, et al. The foramen lacerum: surgical anatomy and relevance for endoscopic endonasal approaches. J Neurosurg. 2018;1–12. [Google Scholar]
  19. You R, Zou X, Wang SL, et al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system. Eur J Cancer (Oxford, England: 1990). 2015;51(13):1771–9. [Google Scholar]
  20. You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma – A case-matched comparison. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2015;115(3):399–406. [Google Scholar]
  21. Ji MF, Huang QH, Yu X, et al. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer. 2014;120(9):1353–60. [CrossRef] [PubMed] [Google Scholar]
  22. Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. New Engl J Med. 2017;377(6):513–22. [Google Scholar]
  23. Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma. Cancer Commun (London, England). 2019;39(1):75. [Google Scholar]
  24. Li YZ, Xie CM, Wu YP, et al. Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm. AJR Am J Roentgenol. 2015;204(1):20–3. [CrossRef] [PubMed] [Google Scholar]
  25. Xiao W, Liu S, Tian Y, et al. Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy. PloS One. 2015;10(4):e0125351. [CrossRef] [PubMed] [Google Scholar]
  26. He YX, Wang Y, Cao PF, et al. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy. Chin J Cancer. 2016;35(1):96. [CrossRef] [PubMed] [Google Scholar]
  27. Peng H, Chen L, Tang LL, et al. Significant value of (18)F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Chin J Cancer. 2017;36(1):95. [CrossRef] [PubMed] [Google Scholar]
  28. Huang L, Chua MLK. Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty. Cancer Commun (London, England). 2020; 40(2–3):119–121. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.